Sanjay Shukla - Dec 11, 2023 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
President and CEO, Director
Signature
/s/ Nancy E. Denyes, Attorney-in-Fact
Stock symbol
LIFE
Transactions as of
Dec 11, 2023
Transactions value $
$17,646
Form type
4
Date filed
12/12/2023, 06:50 PM
Previous filing
Nov 13, 2023
Next filing
Jan 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $3.51K +3K +3.29% $1.17 94.2K Dec 11, 2023 Direct
transaction LIFE Common Stock Purchase $14.1K +12K +12.74% $1.18 106K Dec 12, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.175 to $1.18 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.